azacitidine and Benign Monoclonal Gammopathies

azacitidine has been researched along with Benign Monoclonal Gammopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nohgawa, M; Oka, S; Ono, K	1

Other Studies

1 other study(ies) available for azacitidine and Benign Monoclonal Gammopathies

Article	Year
The effect of azacitidine therapy on the M protein of MDS patients with concomitant MGUS. American journal of hematology, 2018, Volume: 93, Issue:9 Topics: Azacitidine; Bone Marrow Examination; Disease Progression; Female; Humans; Interleukin-6; Japan; Male; Monoclonal Gammopathy of Undetermined Significance; Myelodysplastic Syndromes; Myeloma Proteins; Retrospective Studies; Tumor Suppressor Protein p53	2018

Article

Year

The effect of azacitidine therapy on the M protein of MDS patients with concomitant MGUS.

American journal of hematology, 2018, Volume: 93, Issue:9

Topics: Azacitidine; Bone Marrow Examination; Disease Progression; Female; Humans; Interleukin-6; Japan; Male; Monoclonal Gammopathy of Undetermined Significance; Myelodysplastic Syndromes; Myeloma Proteins; Retrospective Studies; Tumor Suppressor Protein p53

2018